Course curriculum

    1. What are the updates?

    1. Female: Key milestones leading to FDA label changes in February 2026 and evolving evidence on risks and benefits

    2. PDF Download: Female - Key milestones leading to FDA label changes in February 2026 and evolving evidence on risks and benefits

    1. Male - Key milestones leading to FDA label changes in February 2026 and evolving evidence on risks and benefits

    2. PDF Download: Male - Key milestones leading to FDA label changes in February 2026 and evolving evidence on risks and benefits

    1. A Clinical Guide for Providers: Use of Incretin Therapies (GLP-1s) for Women on HRT with Progesterone guidance.

    2. PDF Download: A Clinical Guide for Providers: Use of Incretin Therapies (GLP-1s) for Women on HRT with Progesterone guidance.

    3. Reference: British Menopause Society - Use of incretin-based therapies in women using HRT

About this course

  • Free
  • 8 lessons
  • 0.5 hours of video content